There is no denying that change is the single most prominent theme in healthcare today. Most people point to change imposed by the government including concepts to constrain pharmaceutical drug prices and morph or repeal the Affordable Care Act, or Obamacare. However, most of the change is being driven by health players themselves – payers, providers, technologists, pharmaceutical manufacturers, and, to an increasing extent, consumers.
While it’s impossible to predict the final configuration, it is feasible to capture the primary factors involved in or driving the transformation. Reviewing our recent engagements with major corporations across the healthcare industry, speaking with executives at conferences such as the Blue Cross Blue Shield Summit, the HealthSmart IT event, and several pharmaceutical tradeshows, we’ve identified some of the top issues that are driving
To label these as definitive would deny the very essence of the transformation afoot. Yet, these are, as of now, critical issues affecting the industry.